Compositions comprising ADDL receptor syngap
Details for Australian Patent Application No. 2005244013 (hide)
International Classifications
Event Publications
7 December 2006 PCT application entered the National Phase
PCT publication WO2005/110056 Priority application(s): WO2005/110056
20 September 2007 Change of Name(s) of Applicant(s), Section 104
Northwestern University; Acumen Pharmaceuticals The name of the applicant has been changed to Northwestern University; Acumen Pharmaceuticals, Inc.
12 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005244012-Prolongation of survival of an allograft by inhibiting complement activity
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser